Ratings ArborGen Holdings Limited

Equities

End-of-day quote New Zealand S.E. Other stock markets 18:00:00 2024-07-02 EDT			5-day change	1st Jan Change
0.15 ^NZD	+3.45%		+3.45%	-11.24%

07-02	New Zealand Shares Flat on Weakening Business Confidence; Scott Technology Secures NZ$19 Million Contracts in Europe	MT
07-02	ArborGen Completes Sale of In-Vitro Seedling Business	MT

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality